These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 1620550

  • 1. Correlation between the conformational phenotype of p53 and its subcellular location.
    Zerrahn J, Deppert W, Weidemann D, Patschinsky T, Richards F, Milner J.
    Oncogene; 1992 Jul; 7(7):1371-81. PubMed ID: 1620550
    [Abstract] [Full Text] [Related]

  • 2. Partially transformed T3T3 cells express high levels of mutant p53 in the 'wild-type' immunoreactive form with defective oligomerization.
    Milner J, Chan YS, Medcalf EA, Wang Y, Eckhart W.
    Oncogene; 1993 Jul; 8(7):2001-8. PubMed ID: 8510941
    [Abstract] [Full Text] [Related]

  • 3. Specific and complex interactions of murine p53 with DNA.
    Weissker SN, Müller BF, Homfeld A, Deppert W.
    Oncogene; 1992 Oct; 7(10):1921-32. PubMed ID: 1408133
    [Abstract] [Full Text] [Related]

  • 4. A PAb240+ conformation of wild type p53 binds DNA.
    McLure KG, Lee PW.
    Oncogene; 1996 Sep 19; 13(6):1297-303. PubMed ID: 8808704
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. p53-associated 3'-->5' exonuclease activity in nuclear and cytoplasmic compartments of cells.
    Lilling G, Elena N, Sidi Y, Bakhanashvili M.
    Oncogene; 2003 Jan 16; 22(2):233-45. PubMed ID: 12527892
    [Abstract] [Full Text] [Related]

  • 10. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells.
    Shaulsky G, Ben-Ze'ev A, Rotter V.
    Oncogene; 1990 Nov 16; 5(11):1707-11. PubMed ID: 2267137
    [Abstract] [Full Text] [Related]

  • 11. Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein.
    Milner J, Watson JV.
    Oncogene; 1990 Nov 16; 5(11):1683-90. PubMed ID: 2176282
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The p53 tumor suppressor gene and gene product.
    Levine AJ.
    Princess Takamatsu Symp; 1989 Nov 16; 20():221-30. PubMed ID: 2488233
    [Abstract] [Full Text] [Related]

  • 14. Geldanamycin selectively destabilizes and conformationally alters mutated p53.
    Blagosklonny MV, Toretsky J, Neckers L.
    Oncogene; 1995 Sep 07; 11(5):933-9. PubMed ID: 7675452
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
    Swamy MV, Herzog CR, Rao CV.
    Cancer Res; 2003 Sep 01; 63(17):5239-42. PubMed ID: 14500353
    [Abstract] [Full Text] [Related]

  • 16. Involvement of wild-type p53 protein in the cell cycle requires nuclear localization.
    Shaulsky G, Goldfinger N, Peled A, Rotter V.
    Cell Growth Differ; 1991 Dec 01; 2(12):661-7. PubMed ID: 1809377
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of SV40 large T antigen and p53 on nuclear transport capacity in BALB/c 3T3 cells.
    Feldherr C, Cole C, Lanford RE, Akin D.
    Exp Cell Res; 1994 Jul 01; 213(1):164-71. PubMed ID: 8020587
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.